BTC Capital Management Inc. acquired a new stake in shares of Novo Nordisk A/S (NYSE:NVO) during the second quarter, Holdings Channel reports. The institutional investor acquired 5,138 shares of the company’s stock, valued at approximately $221,000.

Other institutional investors also recently bought and sold shares of the company. Huntington National Bank increased its position in Novo Nordisk A/S by 119.5% in the first quarter. Huntington National Bank now owns 18,103 shares of the company’s stock valued at $620,000 after buying an additional 9,857 shares during the period. Ledyard National Bank increased its position in Novo Nordisk A/S by 225.5% in the first quarter. Ledyard National Bank now owns 145,322 shares of the company’s stock valued at $4,982,000 after buying an additional 100,670 shares during the period. Alta Capital Management LLC increased its position in Novo Nordisk A/S by 11.1% in the first quarter. Alta Capital Management LLC now owns 922,362 shares of the company’s stock valued at $31,618,000 after buying an additional 92,509 shares during the period. Reliance Trust Co. of Delaware increased its position in Novo Nordisk A/S by 42.3% in the first quarter. Reliance Trust Co. of Delaware now owns 22,977 shares of the company’s stock valued at $788,000 after buying an additional 6,829 shares during the period. Finally, Howland Capital Management LLC bought a new position in Novo Nordisk A/S during the first quarter valued at about $266,000. Hedge funds and other institutional investors own 6.40% of the company’s stock.

Novo Nordisk A/S (NYSE NVO) opened at 45.81 on Friday. Novo Nordisk A/S has a one year low of $30.89 and a one year high of $47.98. The firm has a market cap of $113.68 billion, a P/E ratio of 18.74 and a beta of 0.63. The company has a 50-day moving average of $42.76 and a 200 day moving average of $38.81.

The firm also recently announced an annual dividend, which will be paid on Tuesday, August 29th. Investors of record on Monday, August 21st will be paid a dividend of $0.336 per share. This is a boost from Novo Nordisk A/S’s previous annual dividend of $0.33. The ex-dividend date of this dividend is Friday, August 18th. This represents a yield of 1.07%. Novo Nordisk A/S’s payout ratio is presently 36.00%.

COPYRIGHT VIOLATION WARNING: “5,138 Shares in Novo Nordisk A/S (NVO) Acquired by BTC Capital Management Inc.” was posted by Watch List News and is the sole property of of Watch List News. If you are accessing this article on another site, it was stolen and reposted in violation of US and international copyright and trademark legislation. The legal version of this article can be read at https://www.watchlistnews.com/5138-shares-in-novo-nordisk-as-nvo-acquired-by-btc-capital-management-inc/1478290.html.

Several equities analysts have recently issued reports on the stock. BidaskClub upgraded shares of Novo Nordisk A/S from a “sell” rating to a “hold” rating in a report on Saturday. Zacks Investment Research upgraded shares of Novo Nordisk A/S from a “hold” rating to a “buy” rating and set a $49.00 price objective on the stock in a report on Wednesday, June 21st. Finally, TheStreet upgraded shares of Novo Nordisk A/S from a “c+” rating to a “b-” rating in a report on Tuesday, May 2nd. Four analysts have rated the stock with a sell rating, eight have assigned a hold rating and four have issued a buy rating to the stock. Novo Nordisk A/S presently has an average rating of “Hold” and an average target price of $53.00.

Novo Nordisk A/S Company Profile

Novo Nordisk A/S is a global healthcare company engaged in diabetes care. The Company is also engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The Company operates through two business segments: diabetes and obesity care, and biopharmaceuticals. The Company’s diabetes and obesity care segment covers insulin, GLP-1, other protein-related products, such as glucagon, protein-related delivery systems and needles, and oral anti-diabetic drugs.

Want to see what other hedge funds are holding NVO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Novo Nordisk A/S (NYSE:NVO).

Institutional Ownership by Quarter for Novo Nordisk A/S (NYSE:NVO)

Receive News & Ratings for Novo Nordisk A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novo Nordisk A/S and related companies with Analyst Ratings Network's FREE daily email newsletter.